11月26日，纽威股份跌0.40%，成交额2.57亿元。两融数据显示，当日纽威股份获融资买入额2282.10万 元，融资偿还958.05万元，融资净买入1324.05万元。截至11月26日，纽威股份融资融券余额合计1.44亿 元。 截至9月30日，纽威股份股东户数1.38万，较上期增加10.65%；人均流通股54711股，较上期减少 9.63%。2025年1月-9月，纽威股份实现营业收入56.03亿元，同比增长25.76%；归母净利润11.14亿元， 同比增长34.54%。 分红方面，纽威股份A股上市后累计派现45.98亿元。近三年，累计派现22.80亿元。 机构持仓方面，截止2025年9月30日，纽威股份十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1.03亿股，相比上期增加4056.53万股。嘉实价值长青混合A（010273）位居第九大流通股 东，持股640.16万股，相比上期减少299.98万股。嘉实价值臻选混合A（011518）位居第十大流通股 东，持股310.40万股，为新进股东。嘉实价值驱动一年持有期混合A（012533）退出十大流通股东之 列。 责任编辑：小浪快报 融资方面，纽威 ...

证券日报网讯 11月26日晚间，中核科技发布公告称，为进一步加强与投资者的互动交流，中核苏阀科 技实业股份有限公司（以下简称"公司"）将参加"2025苏州上市公司投资者集体接待日"活动，活动时间 为2025年12月2日。 （编辑 姚尧） ...

天眼查App显示，近日，上海航侨阀门有限公司成立，法定代表人为黄思虹，注册资本50万人民币，经 营范围为一般项目：阀门和旋塞研发；阀门和旋塞销售；普通阀门和旋塞制造(不含特种设备制造）； 建筑材料销售；管道运输设备销售；五金产品批发；消防器材销售；电子专用设备销售；环境保护专用 设备销售；金属制品销售；仪器仪表销售；光伏设备及元器件销售。（除依法须经批准的项目外，凭营 业执照依法自主开展经营活动）。 ...

同时该局深入推进知识产权质押融资入园惠企专项行动，发挥知识产权专员作用，深入东方食品城、县 城工业园等重点园区开展"一对一"走访调研，精准摸排高新技术企业融资诉求。截至目前，成功帮助县 域3家企业通过专利权质押获得贷款6500万元，高效破解企业"融资难、融资贵"瓶颈，为企业扩大生产 规模、县域特色产业升级注入了强劲金融动力。 展望未来，隆尧县市场监管局将持续加码发力，深入推进知识产权质押融资入园惠企专项行动，进一步 强化与金融机构的协同联动机制，推动更多知识产权创新成果转化为企业发展"真金白银"，让科技型中 小企业切实享受政策红利，为县域经济高质量发展注入持久活力。 中国质量新闻网讯（刘俊霞 记者徐东周）近日，河北万协兴阀门有限公司以其拥有的9件实用新型专 利，成功从中国银行隆尧分行获得500万元质押贷款，为企业拓宽了融资新渠道，该公司法人代表胡银 辉说："这笔贷款为企业扩大生产及时注入了金融'活水'，让公司生产线扩张、技术升级有了坚实支 撑，这都得益于知识产权质押融资政策！" 今年以来，河北省隆尧县市场监管局精准锚定科技型中小企业融资痛点，以知识产权质押融资为核心抓 手，多维度搭建银企对接平台，联合中国银行 ...

Core Viewpoint - Jiangsu Shentong (002438) has solidified its market position as a leading supplier of critical nuclear-grade valves and has made significant advancements in product innovation and technology [1] Company Developments - The company has launched new products to expand its market share through continuous research and development [1] - The total order value for various valves provided for a single nuclear power unit has exceeded 80 million RMB [1] - The wholly-owned subsidiary Wuxi Flange has secured orders for nuclear forgings exceeding 20 million RMB for a single nuclear power unit [1] Future Outlook - The company plans to increase R&D investment to meet the growing demand for valves and flanges in domestic nuclear power construction [1] - The company aims to contribute more significantly to national energy development [1]

Group 1 - The company announced the repurchase and cancellation of certain restricted stocks and the adjustment of the repurchase price for the 2023 restricted stock incentive plan [2][5] - The total number of shares increased from 749,062,000 to 775,596,927, and the registered capital increased from 749,062,000 yuan to 775,596,927 yuan due to the issuance of restricted stocks [3][4] - The company will repurchase and cancel a total of 314,028 restricted stocks, reducing the total number of shares to 775,282,899 and the registered capital to 775,282,899 yuan [7] Group 2 - The company notified creditors about the reduction in registered capital due to the repurchase of restricted stocks, allowing them to claim debts or request guarantees within 45 days [5][8] - Creditors must provide relevant documents to prove their claims, including contracts and identification [8][9] - The announcement includes details on how creditors can submit their claims, including the timeframe and required materials [9][10]

Core Points - Yonghe Zhikong plans to publicly transfer 100% equity of Kunming Medical Oncology Hospital with a minimum listing price of 35.93 million yuan, marking a complete exit from the healthcare sector after divesting all four private hospitals since 2020 [2] - The acquisition of Kunming Medical was made in 2020 for 108 million yuan, resulting in goodwill of 71.15 million yuan, with the current listing price reflecting a discount of approximately 70% compared to the initial acquisition cost [2] - The company has also listed for sale the equity stakes of its other hospitals, including Dazhou Medical Oncology Hospital (95% stake at 27.68 million yuan), Liangshan High-tech Oncology Hospital (70% stake at 9.37 million yuan), and Xi'an Medical Oncology Hospital (73% stake) along with a debt claim of 14.93 million yuan [2] - The divestment aims to optimize the company's industrial structure and improve the quality of development [2] Financial Performance - After the acquisition, both Kunming Medical and Xi'an Medical reported losses in 2022, while Dazhou Medical and Liangshan High-tech also faced losses in 2023, with all four hospitals continuing to incur losses into the first half of 2024 [3]

Core Viewpoint - Jiangsu Shentong (002438.SZ) indicates that the nuclear valve sector is characterized by complementary and healthy competition among domestic peers, with expectations for orderly competition as new nuclear projects are approved and key equipment localization progresses [1] Industry Summary - The nuclear valve industry is expected to maintain a good and orderly competitive state due to the normalization of new nuclear project approvals and the advancement of domestic key equipment [1] - The company currently has 150,000 nuclear valves online, with a market share exceeding 90% for its main products, including nuclear-grade butterfly and ball valves [1] - The impact of controllable nuclear fusion on the valve industry is primarily seen in technological upgrades and increased market demand [1] - The global acceleration of controllable nuclear fusion industrialization and the critical phase of nuclear fusion experimental reactor construction necessitate valves that can meet extreme working conditions [1] - If controllable nuclear fusion achieves commercialization, the valve sector as a supporting industry is expected to encounter long-term opportunities [1]

Core Insights - On November 19, Nuwai Co., Ltd. saw a stock increase of 1.24% with a trading volume of 174 million yuan, indicating positive market sentiment [1] - The company reported a financing buy amount of 6.03 million yuan and a financing repayment of 12.66 million yuan on the same day, resulting in a net financing outflow of 6.62 million yuan [1] - As of November 19, the total margin balance for Nuwai Co. was 130 million yuan, with a financing balance of 129 million yuan, representing 0.34% of the circulating market value, which is above the 90th percentile of the past year [1] Financial Performance - For the period from January to September 2025, Nuwai Co. achieved a revenue of 5.60 billion yuan, reflecting a year-on-year growth of 25.76% [2] - The net profit attributable to shareholders for the same period was 1.11 billion yuan, marking a year-on-year increase of 34.54% [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Nuwai Co. increased by 10.65% to 13,800, while the average circulating shares per person decreased by 9.63% to 54,711 shares [2] - The company has distributed a total of 4.60 billion yuan in dividends since its A-share listing, with 2.28 billion yuan distributed over the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third largest with 103 million shares, an increase of 40.57 million shares from the previous period [3]

Core Viewpoint - The successful delivery of hydraulic high-pressure gate valves by Yandian Group to South American clients highlights the company's capability in custom product development and adherence to international standards [1] Product Development - The hydraulic high-pressure gate valves were specifically designed and developed to meet the unique operational requirements of the client [1] - The product features a valve body forged from high-quality alloy steel and is equipped with a hydraulic drive system [1] Performance and Standards - The valves exhibit rapid opening and closing response, stable sealing performance, and are capable of long-term, trouble-free operation in complex media environments [1] - The valves comply with API 6A international standards and have undergone multiple strength and sealing tests, meeting all performance indicators as per client expectations [1] Application and Impact - These valves will be directly applied in the fluid control systems of the client's critical production facilities, supporting improvements in production efficiency and ensuring operational safety [1]